Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone added to antibiotics for septic arthritis
IRCT20190903044679N1Phase 3Completed
- Sponsor
- Qazvin University of Medical Sciences
- Start
- Oct 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of dexamethasone in infectious arthritis (SA) (2 arms), sponsored by Qazvin University of Medical Sciences. Primary endpoints: Duration of hospitalization, Duration of symptoms and 1 more. Started Oct 2019; status: completed.
02
Drugs
dexamethasone
03
Conditions
infectious arthritis (SA)
Beyond the preview
Go deeper on IRCT20190903044679N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190903044679N1.